在急性偏头痛治疗中未满足的需求
Enrico Bentivegna1, Silvia Galastri2, Dilara Onan2,3
1Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University, Via di Grottarossa 1035-1039, 00189, Rome, Italy. enrico.bentivegna@uniroma1.it.
Advances in therapy
|November 9, 2023
概括
偏头痛治疗面临的挑战是安全性,可访问性和有限的选择. 像CGRP单克隆抗体这样的新疗法显示出希望,但仍然存在未满足的需求,需要战略性急性和预防性治疗方法.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 关于残疾人的研究.
背景情况:
- 偏头痛是全球神经障碍的主要原因,影响数百万.
- 目前的治疗限制包括安全问题,耐受性差以及可访问性问题.
- 医疗保健提供者的教育和专家的可用性是最佳护理的重大障碍.
研究的目的:
- 为了确定急性偏头痛治疗的关键未满足需求.
- 分析当前急性和预防性偏头痛疗法的疗效和局限性.
- 强调偏头痛管理综合治疗策略的重要性.
主要方法:
- 关于急性和预防性偏头痛治疗的现有文献的审查.
- 对治疗方案的分析,包括传统药物,单克隆抗体, gepants 和 ditans.
- 评估各种治疗方式的安全性,有效性和可访问性.
主要成果:
- 传统的治疗方法如NSAIDs和triptans已知副作用;阿片类药物被过度使用.
- 反CGRP单克隆抗体提供了有针对性的预防方法,具有有利的安全性.
- 新兴的治疗方法,如 gepants 和 ditans 显示出潜在的急性攻击与更少的禁忌.
结论:
- 尽管最近的治疗进展,在偏头痛管理方面仍然存在重大未满足的需求.
- 优化治疗需要急性和预防性治疗的战略组合.
- 进一步的研究和改进的临床策略对于解决偏头痛护理持续存在的挑战至关重要.
相关概念视频
Analgesia and Pain Management
634
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
634
Drug Delivery: Enteral Route
468
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
468
Adrenergic Agonists: Therapeutic Uses
818
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
818
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
170
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
170
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
216
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
216
Cholinergic Antagonists: Therapeutic Uses
758
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
758


